These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7763443)
1. Improvement in the titer of echinocandin-type antibiotics: a magnesium-limited medium supporting the biphasic production of pneumocandins A0 and B0. Tkacz JS; Giacobbe RA; Monaghan RL J Ind Microbiol; 1993 Feb; 11(2):95-103. PubMed ID: 7763443 [TBL] [Abstract][Full Text] [Related]
2. Pneumocandins from Zalerion arboricola. V. Glutamic acid- and leucine-derived amino acids in pneumocandin A0 (L-671,329) and distinct origins of the substituted proline residues in pneumocandins A0 and B0. Adefarati AA; Hensens OD; Jones ET; Tkacz JS J Antibiot (Tokyo); 1992 Dec; 45(12):1953-7. PubMed ID: 1362720 [No Abstract] [Full Text] [Related]
3. Pneumocandins from Zalerion arboricola. II. Modification of product spectrum by mutation and medium manipulation. Masurekar PS; Fountoulakis JM; Hallada TC; Sosa MS; Kaplan L J Antibiot (Tokyo); 1992 Dec; 45(12):1867-74. PubMed ID: 1490877 [TBL] [Abstract][Full Text] [Related]
4. Pneumocandins from Zalerion arboricola. I. Discovery and isolation. Schwartz RE; Sesin DF; Joshua H; Wilson KE; Kempf AJ; Goklen KA; Kuehner D; Gailliot P; Gleason C; White R J Antibiot (Tokyo); 1992 Dec; 45(12):1853-66. PubMed ID: 1490876 [TBL] [Abstract][Full Text] [Related]
5. Pneumocandins from Zalerion arboricola. III. Structure elucidation. Hensens OD; Liesch JM; Zink DL; Smith JL; Wichmann CF; Schwartz RE J Antibiot (Tokyo); 1992 Dec; 45(12):1875-85. PubMed ID: 1490878 [TBL] [Abstract][Full Text] [Related]
7. Residual fructose and osmolality affect the levels of pneumocandins B0 and C0 produced by Glarea lozoyensis. Connors N; Petersen L; Hughes R; Saini K; Olewinski R; Salmon P Appl Microbiol Biotechnol; 2000 Dec; 54(6):814-8. PubMed ID: 11152074 [TBL] [Abstract][Full Text] [Related]
8. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species. Schmatz DM; Abruzzo G; Powles MA; McFadden DC; Balkovec JM; Black RM; Nollstadt K; Bartizal K J Antibiot (Tokyo); 1992 Dec; 45(12):1886-91. PubMed ID: 1490879 [TBL] [Abstract][Full Text] [Related]
9. Engineering of Glarea lozoyensis for exclusive production of the pneumocandin B0 precursor of the antifungal drug caspofungin acetate. Chen L; Yue Q; Li Y; Niu X; Xiang M; Wang W; Bills GF; Liu X; An Z Appl Environ Microbiol; 2015 Mar; 81(5):1550-8. PubMed ID: 25527531 [TBL] [Abstract][Full Text] [Related]
10. Cryptic Production of Mattay J; Houwaart S; Hüttel W Appl Environ Microbiol; 2018 Apr; 84(7):. PubMed ID: 29352089 [TBL] [Abstract][Full Text] [Related]
11. Novel osmotic stress control strategy for improved pneumocandin B Song P; Huang B; Zhang S; Zhang K; Yuan K; Ji X; Ren L; Wen J; Huang H Appl Microbiol Biotechnol; 2018 Dec; 102(24):10729-10742. PubMed ID: 30413850 [TBL] [Abstract][Full Text] [Related]
12. Influence of the culture medium on the production of iturin A by Bacillus subtilis. Besson F; Chevanet C; Michel G J Gen Microbiol; 1987 Mar; 133(3):767-72. PubMed ID: 3116164 [TBL] [Abstract][Full Text] [Related]
13. Effects of amino acid and trace element supplementation on pneumocandin production by Glarea lozoyensis: impact on titer, analogue levels, and the identification of new analogues of pneumocandin B(0). Petersen LA; Hughes DL; Hughes R; DiMichele L; Salmon P; Connors N J Ind Microbiol Biotechnol; 2001 Apr; 26(4):216-21. PubMed ID: 11464269 [TBL] [Abstract][Full Text] [Related]
14. L-671,329, a new antifungal agent. I. Fermentation and isolation. Schwartz RE; Giacobbe RA; Bland JA; Monaghan RL J Antibiot (Tokyo); 1989 Feb; 42(2):163-7. PubMed ID: 2647703 [TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of pneumocandin lipopeptides and perspectives for its production and related echinocandins. Li Y; Lan N; Xu L; Yue Q Appl Microbiol Biotechnol; 2018 Dec; 102(23):9881-9891. PubMed ID: 30255232 [TBL] [Abstract][Full Text] [Related]
16. Production of beauvericin by Beauveria bassiana on L-methionine enriched medium. Peczyńska-Czoch W; Urbańczyk MJ Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):181-4. PubMed ID: 1804051 [TBL] [Abstract][Full Text] [Related]
17. Effect of SDS on release of intracellular pneumocandin B Yuan K; Huang B; Qin T; Song P; Zhang K; Ji X; Ren L; Zhang S; Huang H Appl Microbiol Biotechnol; 2019 Aug; 103(15):6061-6069. PubMed ID: 31161390 [TBL] [Abstract][Full Text] [Related]
18. Pilot-scale process sensitivity studies for the scaleup of a fungal fermentation for the production of pneumocandins. Pollard DJ; Kirschner TF; Hernandez D; Hunt G; Olewinski R; Salmon PM Biotechnol Bioeng; 2002 May; 78(3):270-9. PubMed ID: 11920443 [TBL] [Abstract][Full Text] [Related]
19. [Patterns of the directed biosynthesis of trichothecin and fibrinolytic enzymes in Trichothecium roseum]. Maksimov VN; Maksimova RA; Minaeva TA Mikrobiologiia; 1980; 49(2):258-64. PubMed ID: 6993881 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic production and biocontrol activity by Bacillus subtilis CL27 and Bacillus pumilus CL45. Leifert C; Li H; Chidburee S; Hampson S; Workman S; Sigee D; Epton HA; Harbour A J Appl Bacteriol; 1995 Feb; 78(2):97-108. PubMed ID: 7698955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]